BellgrauD.; GoldD.; SelawryH.P.; MooreJ.; FranzusoffA.; DukeR.C.A role for CD95 ligand in preventing graft rejection.Nature377: 630–632; 1995.
2.
FrenchL.E.; HahneM.; ViardI.; RadlgruberG.; ZanoneR.; BeckerK.; MullerC.; TschoppJ.Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.J. Cell. Biol.133: 335–343: 1996.
3.
GriffithT.S.; BrunnerT.; FletcherS.M.; GreenD.R.; FergussonT.A.Fas ligand induced apoptosis as a mechanism of immune privilege.Science270: 1189–1192; 1995.
4.
LauH.T.; YuM.; FontanaA.; StoeckertC.J.Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.Science273: 109–112; 1996.
5.
NagataS.; GoldsteinP.The Fas death factor.Science267: 1449–1456; 1995.
6.
SanbergP.R.; BorlonganC.V.; SaportaS.; CameronD.F.Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain.Nature Biotechnol.14: 1692–1695; 1996.
